Forty Seven (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- February 24, 2016
- Vertical
- Immuno-oncology
- Funding URL
- View Funding Page
- Funding Amount:
- $75,000,000
Company Info
- Company Description
- Forty Seven is a clinical-stage immuno-oncology company that is developing therapies targeting cancer immune evasion pathways.
- Market
- Cancer treatment
- Location
- Menlo Park, CA, USA
- Coinvestors
- Clarus Ventures, Sutter Hill Ventures